Alzheimer's Research
To learn more about Alzheimer’s, memory loss and ongoing clinical trials in this area, visit our Alzheimer’s Disease Research page.
Learn MoreThe reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease.
Participants must have gradual and progressive change in memory function reported by participants or informants for ≥ 6 months
Participants must have MMSE score of 20 to 28 (inclusive) at baseline
Participants must meet 18F flortaucipir PET scan (central read) criteria does not apply to participants in the safety cohort
Participants must have meet 18F florbetapir PET scan (central read) criteria
Participants must have a study partner who will provide written informed consent to participate
To learn more about Alzheimer’s, memory loss and ongoing clinical trials in this area, visit our Alzheimer’s Disease Research page.
Learn MoreTo learn more about neurological disorders and ongoing clinical trials in the area, visit our Neurological Disorders Research page.
A clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.